NIPH Clinical Trials Search

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy (RGX-314 SRLTFU)

Basic Information

Recruitment status	Pending
Health condition(s) or Problem(s) studied	Neovascular age-related macular degeneration
Date of first enrollment	30/04/2026
Target sample size	14
Countries of recruitment	United States,Japan,Puerto Rico,Japan,Canada,Japan,France,Japan,Germany,Japan,Hungary,Japan,Israel,Japan,Italy,Japan,Spain,Japan,United Kingdom,Japan
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	Incidence of ocular adverse events and any serious adverse events in the study eye
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 50age old
Age maximum	Not applicable
Gender	Both
Include criteria	1. Able and willing to provide written consent 2. Previously enrolled in a clinical study of RGX-314 and received a single subretinal administration of RGX-314
Exclude criteria	None